407 related articles for article (PubMed ID: 11402340)
1. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
Vial E; Perez S; Castellazzi M
Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
[TBL] [Abstract][Full Text] [Related]
3. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
4. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
[TBL] [Abstract][Full Text] [Related]
5. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
[TBL] [Abstract][Full Text] [Related]
6. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
7. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
Hughes M; Sehgal A; Hadman M; Bos T
Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
Perez S; Vial E; van Dam H; Castellazzi M
Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
[TBL] [Abstract][Full Text] [Related]
10. AP-1 transcription factor complexes in CNS disorders and development.
Pennypacker KR
J Fla Med Assoc; 1995 Aug; 82(8):551-4. PubMed ID: 7561734
[TBL] [Abstract][Full Text] [Related]
11. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
[TBL] [Abstract][Full Text] [Related]
14. AP-1--Introductory remarks.
Wagner EF
Oncogene; 2001 Apr; 20(19):2334-5. PubMed ID: 11402330
[TBL] [Abstract][Full Text] [Related]
15. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets of the oncogenic transcription factor jun.
Hartl M; Bader AG; Bister K
Curr Cancer Drug Targets; 2003 Feb; 3(1):41-55. PubMed ID: 12570660
[TBL] [Abstract][Full Text] [Related]
17. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
[TBL] [Abstract][Full Text] [Related]
18. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.
Chinenov Y; Kerppola TK
Oncogene; 2001 Apr; 20(19):2438-52. PubMed ID: 11402339
[TBL] [Abstract][Full Text] [Related]
19. Altered protein conformation on DNA binding by Fos and Jun.
Patel L; Abate C; Curran T
Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
[TBL] [Abstract][Full Text] [Related]
20. Injury-specific expression of activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated c-Jun.
Takeda M; Kato H; Takamiya A; Yoshida A; Kiyama H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2412-21. PubMed ID: 10937548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
